Company profile
Evergreen Health Solutions Ltd
askmyGP
Evergreen Health Solutions Ltd is a UK company with status active founded in 2015.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Accounts filed
AccountsLast accounts made up date
Accounts With Accounts Type Group
Accounts PDF pendingAA | Transaction MzQ1NTcwMzA1NWFkaXF6a2N4 | Paper/PDF filed
Published 21 Feb 2025 07:09
Second Filing Of Director Appointment With Name
OfficersRP04AP01 | Transaction MzQ1NTY2OTIwMWFkaXF6a2N4
Published 20 Feb 2025 08:18
Capital Allotment Shares
CapitalSH01 | Transaction MzQ0MDM3NzgxOGFkaXF6a2N4
Published 21 Oct 2024 11:31
Capital Allotment Shares
CapitalSH01 | Transaction MzQzMTkxMTg0N2FkaXF6a2N4
Published 13 Aug 2024 00:32
Appoint Person Director Company With Name Date
OfficersAP01 | Transaction MzExOTI1MDQxMmFkaXF6a2N4 | Paper/PDF filed
Published 21 Feb 2025 08:45
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Using NLP to Target Patient Led and Scalable Primary Care Interactions
1 Apr 2023 to 31 Mar 2026
Collapsing morale among general practitioners (GPs), a shrinking GP workforce, relentless demands, and increasing workload have caused many to sound alarm on a general practice in "crisis" \[1\]. Online Consultation (OC) systems are part of the solution. They help GPs to manage patient requests and workload more effectively while allowing patients to cont...
Predicting kidney and liver damage in cancer patients receiving chemotherapy
1 Aug 2022 to 31 Jul 2024
Chemotherapy is the treatment of disease using chemical substances, commonly used to treat cancer. Chemotherapy is often cytotoxic and two common risks relate to kidney and liver damage. Affected patients may require delays or changes to treatment and even treatment suspension. Whilst only <10% of patients will encounter kidney and or liver damage, curren...